Works matching DE "DARUNAVIR"
Results: 420
Influence of Water-Soluble Pharmaceutically Acceptable Polymers on the Solubility of Darunavir and Darunavir Ethanolate.
- Published in:
- Pharmaceutical Chemistry Journal, 2021, v. 54, n. 12, p. 1274, doi. 10.1007/s11094-021-02354-8
- By:
- Publication type:
- Article
Planning and Assessment of Bioequivalence Studies of Darunavir Preparations.
- Published in:
- Pharmaceutical Chemistry Journal, 2018, v. 52, n. 9, p. 771, doi. 10.1007/s11094-018-1897-z
- By:
- Publication type:
- Article
Methods for Analytical Control of Darunavir Tablet Dosage Forms. Part II.
- Published in:
- Pharmaceutical Chemistry Journal, 2018, v. 52, n. 6, p. 562, doi. 10.1007/s11094-018-1860-z
- By:
- Publication type:
- Article
Analytical Control of Darunavir Tablet Dosage Forms. Part I.
- Published in:
- Pharmaceutical Chemistry Journal, 2018, v. 51, n. 11, p. 1030, doi. 10.1007/s11094-018-1734-4
- By:
- Publication type:
- Article
Issues Related to Patent Protecton of Darunavir and its Analogs.
- Published in:
- Pharmaceutical Chemistry Journal, 2016, v. 50, n. 6, p. 413, doi. 10.1007/s11094-016-1461-7
- By:
- Publication type:
- Article
What´s hot in European Journal of Pharmaceutics and Biopharmaceutics?
- Published in:
- TechnoPharm, 2017, v. 7, n. 4, p. 52
- By:
- Publication type:
- Article
Acquired HIV-1 Protease Conformational Flexibility Associated with Lopinavir Failure May Shape the Outcome of Darunavir Therapy after Antiretroviral Therapy Switch.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 4, p. 489, doi. 10.3390/biom11040489
- By:
- Publication type:
- Article
Lopinavir/Ritonavir Versus Darunavir Plus Ritonavir for HIV Infection: A Cost-Effectiveness Analysis for the United States.
- Published in:
- PharmacoEconomics, 2013, v. 31, n. 5, p. 427, doi. 10.1007/s40273-013-0048-3
- By:
- Publication type:
- Article
Modelling the Budget Impact of Darunavir in the Treatment of Highly Treatment-Experienced, HIV-Infected Adults in France.
- Published in:
- PharmacoEconomics, 2010, v. 28, p. 183, doi. 10.2165/11587520-000000000-00000
- By:
- Publication type:
- Article
Cost Effectiveness of Darunavir/Ritonavir 600/100mg bid in Treatment-Experienced, Lopinavir-Naive, Protease Inhibitor-Resistant, HIV-Infected Adults in Belgium, Italy, Sweden and the UK.
- Published in:
- PharmacoEconomics, 2010, v. 28, p. 147, doi. 10.2165/11587500-000000000-00000
- By:
- Publication type:
- Article
US Cost Effectiveness of Darunavir/Ritonavir 600/100mg bid in Treatment-Experienced, HIV-Infected Adults with Evidence of Protease Inhibitor Resistance Included in the TITAN Trial.
- Published in:
- PharmacoEconomics, 2010, v. 28, p. 129, doi. 10.2165/11587490-000000000-00000
- By:
- Publication type:
- Article
Cost Effectiveness of Darunavir/Ritonavir 600/100mg bid in Protease Inhibitor-Experienced, HIV-1-Infected Adults in Belgium, Italy, Sweden and the UK.
- Published in:
- PharmacoEconomics, 2010, v. 28, p. 107, doi. 10.2165/11587480-000000000-00000
- By:
- Publication type:
- Article
Cost Effectiveness of Darunavir/Ritonavir in Highly Treatment-Experienced, HIV-1-Infected Adults in the USA.
- Published in:
- PharmacoEconomics, 2010, v. 28, p. 83, doi. 10.2165/11587470-000000000-00000
- By:
- Publication type:
- Article
Costs to Achieve Undetectable HIV RNA with Darunavir-Containing Highly Active Antiretroviral Therapy in Highly Pretreated Patients: The POWER Experience.
- Published in:
- PharmacoEconomics, 2010, v. 28, p. 69, doi. 10.2165/11587460-000000000-00000
- By:
- Publication type:
- Article
A Review of Economic Evaluations of Darunavir Boosted by Low-Dose Ritonavir in Treatment-Experienced Persons Living with HIV Infection.
- Published in:
- PharmacoEconomics, 2010, v. 28, p. 1, doi. 10.2165/11587410-000000000-00000
- By:
- Publication type:
- Article
Effectiveness of tipranavir versus darunavir as a salvage therapy in HIV-1 treatment-experienced patients.
- Published in:
- Journal of Infection in Developing Countries, 2016, v. 10, n. 9, p. 982, doi. 10.3855/jidc.6629
- By:
- Publication type:
- Article
Effectiveness of dolutegravir-based regimens compared to raltegravir-, elvitegravir-, bictegravir, and darunavir-based regimens among older adults with HIV in the Veterans Aging Cohort Study (VACS).
- Published in:
- AIDS Research & Therapy, 2024, v. 21, n. 1, p. 1, doi. 10.1186/s12981-024-00681-w
- By:
- Publication type:
- Article
Initiating HIV antiretroviral therapy: Criteria, evidence, and controversy.
- Published in:
- JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2011, v. 24, n. 2, p. 26, doi. 10.1097/01720610-201102000-00005
- By:
- Publication type:
- Article
Double trouble? Gag in conjunction with double insert in HIV protease contributes to reduced DRV susceptibility.
- Published in:
- Biochemical Journal, 2019, v. 476, n. 2, p. 375, doi. 10.1042/BCJ20180692
- By:
- Publication type:
- Article
Importance of multidisciplinary collaboration for smooth kidney transplantation in HIV-infected patients with chronic kidney disease: a case report.
- Published in:
- Renal Replacement Therapy, 2022, v. 8, n. 1, p. 1, doi. 10.1186/s41100-022-00435-2
- By:
- Publication type:
- Article
Exploring Darunavir, Rilpivirine and Etravirine as Potential Therapies for Bladder Cancer: Efficacy and Synergistic Effects.
- Published in:
- Biomedicines, 2024, v. 12, n. 3, p. 647, doi. 10.3390/biomedicines12030647
- By:
- Publication type:
- Article
Comparison of Tolerability and Impact on Metabolic Profiles of Antiretroviral Regimens Containing Darunavir/Ritonavir or Darunavir/Cobicistat in Romanian HIV Infected Patients.
- Published in:
- Biomedicines, 2021, v. 9, n. 8, p. 987, doi. 10.3390/biomedicines9080987
- By:
- Publication type:
- Article
Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat.
- Published in:
- Biomedicines, 2021, v. 9, n. 3, p. 313, doi. 10.3390/biomedicines9030313
- By:
- Publication type:
- Article
Lopinavir inhibits insulin signaling by promoting protein tyrosine phosphatase 1B expression.
- Published in:
- Experimental & Therapeutic Medicine, 2014, v. 8, n. 3, p. 851, doi. 10.3892/etm.2014.1826
- By:
- Publication type:
- Article
Similar plasma lipidomic profile in people living with HIV treated with a darunavir-based or an integrase inhibitor-based antiretroviral therapy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-53761-7
- By:
- Publication type:
- Article
Daily ritonavir‐boosted darunavir for viral suppression in pregnancy (DRV‐P).
- Published in:
- HIV Medicine, 2024, v. 25, n. 1, p. 129, doi. 10.1111/hiv.13546
- By:
- Publication type:
- Article
Immune response to ART initiation in advanced HIV infection.
- Published in:
- HIV Medicine, 2023, v. 24, n. 6, p. 716, doi. 10.1111/hiv.13467
- By:
- Publication type:
- Article
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment‐naïve (AMBER) and virologically suppressed (EMERALD) participants with neurological and/or psychiatric comorbidities: Week 96 subgroup analysis.
- Published in:
- HIV Medicine, 2023, v. 24, n. 3, p. 279, doi. 10.1111/hiv.13377
- By:
- Publication type:
- Article
BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022.
- Published in:
- HIV Medicine, 2022, v. 23, p. 3, doi. 10.1111/hiv.13446
- By:
- Publication type:
- Article
Trends in antiretroviral use in pregnancy in the UK and Ireland, 2008–2018.
- Published in:
- HIV Medicine, 2022, v. 23, n. 4, p. 397, doi. 10.1111/hiv.13243
- By:
- Publication type:
- Article
The effect of protease inhibitor‐based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART‐naïve patients with HIV‐infection.
- Published in:
- HIV Medicine, 2021, v. 22, n. 4, p. 254, doi. 10.1111/hiv.13008
- By:
- Publication type:
- Article
Rapid ART start in early HIV infection: Time to viral load suppression and retention in care in a London cohort.
- Published in:
- HIV Medicine, 2020, v. 21, n. 9, p. 613, doi. 10.1111/hiv.12900
- By:
- Publication type:
- Article
Corrigendum.
- Published in:
- 2019
- Publication type:
- Correction Notice
Reduced exposure to darunavir and cobicistat in HIV‐1‐infected pregnant women receiving a darunavir/cobicistat‐based regimen.
- Published in:
- HIV Medicine, 2019, v. 20, n. 5, p. 337, doi. 10.1111/hiv.12721
- By:
- Publication type:
- Article
Subclinical cardiovascular disease in patients starting contemporary protease inhibitors.
- Published in:
- HIV Medicine, 2018, v. 19, n. 7, p. 497, doi. 10.1111/hiv.12619
- By:
- Publication type:
- Article
Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe.
- Published in:
- HIV Medicine, 2018, v. 19, n. 5, p. 324, doi. 10.1111/hiv.12581
- By:
- Publication type:
- Article
Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia.
- Published in:
- HIV Medicine, 2017, v. 18, n. 10, p. 782, doi. 10.1111/hiv.12530
- By:
- Publication type:
- Article
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection.
- Published in:
- HIV Medicine, 2017, v. 18, n. 7, p. 474, doi. 10.1111/hiv.12478
- By:
- Publication type:
- Article
Week 96 efficacy and safety of darunavir/ritonavir monotherapy vs. darunavir/ritonavir with two nucleoside reverse transcriptase inhibitors in the PROTEA trial.
- Published in:
- HIV Medicine, 2017, v. 18, n. 1, p. 5, doi. 10.1111/hiv.12386
- By:
- Publication type:
- Article
Virological response and resistance profile in HIV-1-infected patients starting darunavir-containing regimens.
- Published in:
- HIV Medicine, 2017, v. 18, n. 1, p. 21, doi. 10.1111/hiv.12388
- By:
- Publication type:
- Article
Pharmacokinetics of once-daily darunavir/ritonavir in HIV-1-infected pregnant women.
- Published in:
- HIV Medicine, 2016, v. 17, n. 9, p. 643, doi. 10.1111/hiv.12366
- By:
- Publication type:
- Article
PEPDar: A randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis.
- Published in:
- HIV Medicine, 2016, v. 17, n. 6, p. 453, doi. 10.1111/hiv.12363
- By:
- Publication type:
- Article
Comparative risk of failure of ABC/3 TC or TDF/ FTC based first-line regimens in patients with a high viral load.
- Published in:
- HIV Medicine, 2016, v. 17, n. 5, p. 380, doi. 10.1111/hiv.12306
- By:
- Publication type:
- Article
The Intelence aNd pRezista Once A Day Study ( INROADS): a multicentre, single-arm, open-label study of etravirine and darunavir/ritonavir as dual therapy in HIV-1-infected early treatment-experienced subjects.
- Published in:
- HIV Medicine, 2015, v. 16, n. 5, p. 288, doi. 10.1111/hiv.12211
- By:
- Publication type:
- Article
Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data.
- Published in:
- HIV Medicine, 2015, v. 16, n. 5, p. 297, doi. 10.1111/hiv.12218
- By:
- Publication type:
- Article
Low concordance and resistance mutation emergence in the HIV protease gene among circulating and cell-associated viruses at viral replication episodes during darunavir/ritonavir monotherapy.
- Published in:
- HIV Medicine, 2015, v. 16, n. 1, p. 57, doi. 10.1111/hiv.12170
- By:
- Publication type:
- Article
Improved serum cholesterol in paediatric patients switched from suppressive lopinavir-based therapy to boosted darunavir or atazanavir: an 18-month retrospective study.
- Published in:
- HIV Medicine, 2014, v. 15, n. 10, p. 635, doi. 10.1111/hiv.12180
- By:
- Publication type:
- Article
Pharmacokinetics and efficacy of darunavir/ritonavir once daily in virologically suppressed, treatment-experienced HIV-infected children.
- Published in:
- HIV Medicine, 2014, v. 15, n. 8, p. 511, doi. 10.1111/hiv.12163
- By:
- Publication type:
- Article
Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 50, doi. 10.1111/hiv.12047
- By:
- Publication type:
- Article
Pharmacokinetic interaction between etravirine or darunavir/ritonavir and artemether/lumefantrine in healthy volunteers: a two-panel, two-way, two-period, randomized trial.
- Published in:
- HIV Medicine, 2013, v. 14, n. 7, p. 421, doi. 10.1111/hiv.12019
- By:
- Publication type:
- Article